Insiders · Profile

Meyers Michael L.

SVP, Chief Medical Officer at Syndax Pharmaceuticals. Filing since 30 Oct 2018. CIK 0001664204

Company

Date

Role

Action

Amount

Of holding

26 Apr 2021

SVP, Chief Medical Officer

Bought

500

$7.73K

3.3%

21 Mar 2019

SVP, Chief Medical Officer

Bought

1,104

$5.44K

18.0%

30 Oct 2018

SVP, Chief Medical Officer

Bought

200

$958.00

9.1%

3 decisions on file.